NK-cell related neoplasms in Osaka, Japan

American Journal of Hematology

Volumn 76, Issue 3, 2004, Pages 230-235

  Miyazato, Hajime ^a   Nakatsuka, Shin Ichi ^b   Dong, Zhiming ^b   Takakuwa, Tetsuya ^b   Oka, Kazumasa ^b   Hanamoto, Hitoshi ^a   Tatsumi, Yoichi ^a   Kanamaru, Akihisa ^a   Aozasa, Katsuyuki ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Clinicopathological findings; Frequency; NK cell related neoplasm

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; KI 67 ANTIGEN; LATENT MEMBRANE PROTEIN 1;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER INCIDENCE; CANCER LOCALIZATION; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; JAPAN; LYMPHOMA; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA;

ANTIGENS, CD56; ANTINEOPLASTIC AGENTS; C-REACTIVE PROTEIN; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; KILLER CELLS, NATURAL; L-LACTATE DEHYDROGENASE; LYMPHOMA, SMALL-CELL; MALE; MIDDLE AGED; RADIOTHERAPY; RECEPTORS, INTERLEUKIN-2;

EID: 3042602309     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20091     Document Type: Article

References (23)

1. Jaffe ES, Harris NL, Stein H, Vardiman J. Pathology and genetics of tumours of haematopoietic and lymphoid tissue. Lyon: IARC; 2001.
2. Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Cancer 1998;83:806-812.
3. Chan JKC, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm, Blood 1997;89: 4501-4513.
4. Cheung MM, Chan JKC, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998;16:70-77.
5. Gerdes J, Lemke H, Baisch H, Jacker HH, Schmab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715.
6. Tokura Y, Ishihara S, Togawa S, Seo N, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of juvenile type or Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol 2001;45: 569-578.
7. Jaffe ES, Chan JK, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis and epidemiology. Am J Surg Pathol 1996;20:103-111.
8. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic location. Ann Oncol 1998;9:717-720.
9. Aozasa K, Ohsawa M, Tajima K, et al. Nation-wide study of lethal midline granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphomas and other related conditions. Int J Cancer 1989;44:63-66.
10. Aozasa K, Yang W-I, Lee Y-B, et al. Lethal midline granuloma in Seoul (Korea) and Shanghai (China). Int J Cancer 1992;52: 673-674.
11. Hongyo T, Li T, Syaifudin M, et al. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan. Cancer Res 2000;60:2345-2347.
12. th Workshop of the Europian Association for Haematopathology. Histopathology 2001;38:250-270.
13. Ho FC, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphomas of nose and upper aerodigestive tract: a clinicopathologic study 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 1990;21:1041-1050.
14. Tomita Y, Ohsawa M, Mishiro Y, et al. The presence and subtype of Epstein-Barr virus in B- and T-cell lymphomas of sino-nasal region from of the Osaka and Okinawa districts of Japan. Lab Invest 1995:73:190-196.
15. Harabuchi Y, Imai S, Wakashima J, et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer 1996;77:2137-2149.
16. Chan JKC, Yip TT, Tsang WY, et al. Detection of Epstein-Barr viral DNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994;18:938-946.
17. Gaal K, Sun NC, Hernandez AM, Arber DA. Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol 2000; 24:1511-1517.
18. Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphomas: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81:2688-2695.
19. Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol 2001;45: 569-578.
20. Mizuki M, Ueda S, Tagawa S, et al. Natural killer cell-derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bite and reactivated Epstein-Barr virus infection. Am J Hematol 1998;59:309-315.
21. Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000;18:54-63.
22. Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin's lymphoma of the nasal cavity. Cancer 1998;83:449-456.
23. Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995;13: 666-670.